Deep Brain Stimulation
92
32
35
22
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.5%
6 terminated out of 92 trials
78.6%
-8.0% vs benchmark
2%
2 trials in Phase 3/4
32%
7 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (92)
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation
A Study of Buntanetap in Participants With PD
Coordinated Reset Deep Brain Stimulation for Parkinson's Disease
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Use of CereGate Therapy for Freezing of Gait in PD
Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
Udall Project 1 Aim 4
A Multicenter Pediatric Deep Brain Stimulation Registry
Sleep-specific DBS Therapy in Parkinson's Disease
Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease
LIFUS For Neurological Disorders
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming